iRadimed Corporation (IRMD) To Go Ex-Dividend on November 13th

iRadimed Corporation (NASDAQ:IRMD) declared a quarterly dividend on Friday, October 30th. Shareholders of record on Friday, November 13th will be paid a dividend of $0.20 per share by the medical equipment provider on Friday, November 27th. This represents a $0.80 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, November 13th.

iRadimed has a dividend payout ratio of 40.2% meaning its dividend is sufficiently covered by earnings.

iRadimed Stock Down 0.5%

Shares of NASDAQ IRMD traded down $0.40 during midday trading on Wednesday, reaching $86.33. 6,221 shares of the stock were exchanged, compared to its average volume of 113,002. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of 46.16 and a beta of 0.91. iRadimed has a twelve month low of $76.35 and a twelve month high of $107.90. The firm has a 50-day simple moving average of $85.33 and a two-hundred day simple moving average of $92.08.

iRadimed (NASDAQ:IRMD) last announced its quarterly earnings data on Friday, October 30th. The medical equipment provider reported $0.55 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.55. The company had revenue of $24.20 million during the quarter, compared to analysts’ expectations of $23.47 million. iRadimed had a net margin of 26.85% and a return on equity of 23.90%. Research analysts expect that iRadimed will post 1.92 EPS for the current fiscal year.

About iRadimed

iRadimed Corporation develops, manufactures and markets medical devices designed for use in magnetic resonance imaging (MRI) environments. Its products include MRI-compatible patient monitoring systems and intravenous infusion pumps, along with related accessories. The company’s monitoring systems help clinicians track patients during MRI procedures, while its infusion pumps deliver fluids and medications in the MRI suite. iRadimed’s equipment is designed to operate in the presence of MRI magnets, where conventional medical devices may not be suitable.